Barclays analyst Luke Sergott maintained a Hold rating on Quest Diagnostics (DGX – Research Report) today and set a price target of $175.00.

Barclays upped their price target on shares of Quest Diagnostics from $168.00 to $175.00 and gave the stock an “equal weight” rating in a research note on Friday, January 31st. StockNews.com ...

Currently, the analyst consensus on Quest Diagnostics is a Moderate Buy with an average price target of $182.80, representing an 11.42% upside. In a report released on March 27, Nephron also ...

However, on the same day, Morgan Stanley reiterated a Buy rating on Quest Diagnostics (NYSE: DGX). DGX market cap is currently $19.14B and has a P/E ratio of 22.50. Based on the recent corporate ...

Shares of UNF stock opened at $163.40 on Friday. UniFirst has a 1-year low of $149.58 and a 1-year high of $243.70. The stock has a market cap of $3.03 billion, a price-to-earnings ratio of 20.89 ...

On Friday, Barclays began coverage on Churchill Downs (NASDAQ:CHDN) shares, assigning an Overweight rating and setting a price target of $125.00. The initiation reflects Barclays' positive outlook ...

Barclays this week propelled its view on the Financials (NYSEARCA:XLF) sector, setting its sights partially on what’s considered to be a looser regulatory environment in Washington. The S&P 500 ...

On Monday, Barclays adjusted its stance on SBM Offshore NV shares, downgrading the company’s stock rating from Overweight to Equal Weight. The new price target has been set at EUR25.00.

On Wednesday, Barclays (LON:BARC) upgraded Norwegian Air Shuttle ASA (OL:NAS:NO) (OTC: NWARF) stock rating from Equalweight to Overweight, also increasing the price target to NOK14.00, up from the ...

Goldman Sachs cuts GSK price target to 1,640 (1,680) pence - 'neutral' Barclays cuts Sage price target to 1,065 (1,080) pence - 'underweight' Barclays cuts Pearson price target to 1,245 (1,330 ...